In the BioHarmony Drug Report Database

"Preview" Icon

Pegloticase

Krystexxa (pegloticase) is an enzyme pharmaceutical. Pegloticase was first approved as Krystexxa on 2010-09-14. It is used to treat gout in the USA.

 

Trade Name

 

Krystexxa
 

Common Name

 

pegloticase
 

ChEMBL ID

 

CHEMBL1237025
 

Indication

 

gout
 

Drug Class

 

Enzymes; PEGylated compounds

Image (chem structure or protein)

Pegloticase structure rendering